Concall Note / Software Services / LTTS

L&T Technology Services delays Tech segment growth, large deal TCV halves as timeline slips

Q1 FY27 large deal wins dropped to ~$100M from ~$200M average; Tech segment recovery pushed to Q2 after management said in April it would return from Q1.

LTTS ISIN INE010V01017 14 Jul 2026 Analysis source: Tijori Concall Monitor

Management consistency flag

In April 2026, management said the Tech segment would return to growth from Q1 FY27. In July 2026, Tech declined and recovery was pushed to Q2. Large deal TCV also fell from ~$200 million average to ~$100 million, attributed to deal timing without specifics.

What's new

Revenue ₹2,940 cr, up 2.9% QoQ, 11.5% YoY
EBIT margin 15.7%, up 50 bps QoQ, 200 bps YoY
Large deal TCV ~$100 million, down from ~$200 million average
Tech segment declined, growth expectation pushed to Q2 FY27

Themes from the call

Demand

Tech segment demand remained measured, with medical program transitions and delayed closes; Sustainability and Mobility showed sequential growth.

Margins

Consolidated EBIT margin expanded 200 bps YoY to 15.7%, driven by mix shift toward high-margin Sustainability (29.1%), offsetting Tech and Mobility pressure.

Guidance Credibility

Two timeline slips (Tech recovery and large deal closures) contrast with earlier confident statements, raising questions about forecasting reliability.

Guidance watch

Mid-16% EBIT margin targeted by Q4 FY27, with sequential margin improvement.
Tech segment expected to return to growth from Q2 FY27 onwards.
Sustainability double-digit growth for FY27 reconfirmed.
Effective tax rate 26.2-26.7%; free cash flow 90-95% of net income for FY27.
Management reiterated sequential revenue and margin growth every quarter of FY27.

Risk flags

Tech segment growth timeline delayed by one quarter; if Q2 also disappoints, credibility damage may persist.
Large deal TCV halved from recent averages; pipeline strength not quantified.
Medical domain headwinds (concluded program, delayed start) could extend if negotiations slip.
Europe macro headwinds and China exposure create uncertainty for Mobility outlook.

Key quotes

"And in Tech, there are three components... And we do believe that next quarter onwards, we should start seeing that growth again."
— Amit Chadha, CEO (Apr 2026 call)
"In Q1, we recorded large deal TCV wins of nearly $100 million, with a few large deal wins that were supposed to close in Q1 having moved to the early part of Q2."
— Amit Chadha, CEO (Jul 2026 call)

The brief

LTTS delivered a solid quarter by the numbers: revenue up 2.9% sequentially, margins expanding 200 bps year-on-year to 15.7%, and free cash flow at 153% of net income. But the narrative was undercut by two timeline slips that management had set in the previous call. Tech segment, which was supposed to return to growth from Q1, instead declined. Large deal TCV halved to ~$100 million from a consistent ~$200 million average. Both were attributed to deal timing and a concluded medical program, but the explanations lean on hope rather than concrete evidence. Outside Tech, the picture is stronger. Sustainability grew 11% YoY with 29.1% margins, and Mobility is recovering on new vehicle programs. Management reaffirmed sequential growth for FY27 and a mid-16% EBIT margin target by Q4. But the slip in the Tech timeline, now Q2, makes that guidance harder to underwrite. If Q2 delivers the promised Tech recovery and a telecom deal closes, the credibility dent may heal. If not, the slips will start to look like a pattern.

The take

LTTS delivered on margins but slipped on timelines. Q2 will test whether the delays are transient or systemic.

Source Tijori Concall Monitor analysis This brief is derived from Tijori's call-monitor analysis, not the exchange transcript source of record. Verify material claims against the company's call materials where available.